@EASDelearning

Explore the EASD e-Learning platform for high-quality, up-to-date education in diabetes care and research.

easd-elearning.eu
Joined November 2019
  • Tweets10.7K
  • Following1.8K
  • Followers5.2K
3KMedia
We found a disruption to the seasonal pattern but no overall increase in the expected incidence of pediatric diabetes during the first three years of the COVID-19 pandemic in Ontario, Canada. @ADA_Pubs Read Here➡️doi.org/10.2337/dc23-1794

Disruption to Pattern but No Overall Increase in the Expected Incidence of Pediatric Diabetes...

There is an emerging concern that the incidence of pediatric diabetes has increased since the coronavirus disease 2019 (COVID-19) pandemic. We previously r

diabetesjournals.org
2
4
963
EASDelearning retweeted
The Lancet
@TheLancet28 Dec 2023
People with diabetes often encounter stigma which can adversely affect their health. In @TheLancetEndo, authors call on the health community to endorse an evidence-based pledge to proactively challenge, & bring an end to, diabetes stigma & discrimination. hubs.li/Q02dRnmQ0
Panel listing definitions of diabetes stigma and discrimination. Copyright: 2023 Elsevier Ltd. All rights reserved.

ALT Panel listing definitions of diabetes stigma and discrimination. Copyright: 2023 Elsevier Ltd. All rights reserved.

15
1
26
13,726
These data define pathophysiological underpinnings of the tree structure, which has the potential to stratify #diabetes-related complications on the basis of routinely available variables & thereby expand the toolbox of precision diabetes diagnosis thelancet.com/journals/landi… #T2D
14
22
2,647
🚨🚨🚨Real‐world effectiveness and safety of oral semaglutide in people living with T2D: A nationwide multicentre retrospective observational study (ENDO2S‐RWD) Diabetes, Obesity and Metabolism dom-pubs.pericles-prod.liter… 🆓 @sociedadSEEN @SENefrologia @secardiologia @SEMERGENap
5
15
1
35
5,022
Psychosocial care for people with diabetic neuropathy needs attention from both clinicians and researchers: a call for action. @ADA_Pubs Read Here➡️doi.org/10.2337/dci23-0033
Graphical Abstract

ALT Graphical Abstract

3
11
897
Both continuous and intermittently scanned continuous glucose monitoring provide significant reductions in HbA1c compared to usual care, with no adverse impact on hypoglycemia. @ADA_Pubs Read Here➡️doi.org/10.2337/dc23-1520
Graphical Abstract

ALT Graphical Abstract

3
7
1,043
Our paper Inequalities the management of diabetic kidney disease in UK primary care: A cross‐sectional analysis of a large primary care database - ⁦@idasgupta7⁩ ⁦@Nirantharakumar⁩ ⁦@sribellary⁩ ⁦@m_alikaramat⁩ ⁦@hazlehurst_j⁩ onlinelibrary.wiley.com/doi/…

Diabetic Medicine | Diabetes UK Journal | Wiley Online Library

Aims To determine differences in the management of diabetic kidney disease (DKD) relevant to patient sex, ethnicity and socio-economic group in UK primary care. Methods A cross-sectional analysis a...

onlinelibrary.wiley.com
7
12
1,172
#GLP1ReceptorAgonists are associated with lower incidences of adverse cardiovascular events and all-cause mortality in individuals with #NAFLD and #type2diabetes, compared with other glucose-lowering medications @DrAKrishnanMD #matchedcohortstudy tinyurl.com/2ef8unpm 🔓
1
11
32
3,816
Everything you need when designing a study to investigate hepatic glucose uptake with FDG PET: getting us one step closer to unravelling the relationship between #diabetes and liver glucose metabolism tinyurl.com/2ksp24zv
5
1
20
2,181
‘A blog to show case 10 folks or groups who –in my opinion-deserve a mention for their work which has helped many with #Diabetes through the year’ The “Top 10” for 2023 Thank you from me for all the work you all continue to do in challenging times Link: nhssugardoc.blogspot.com/202…
6
8
6
74
24,435
EASDelearning retweeted
Filip K. Knop@Filip_Knop27 Dec 2023
Here, the brilliant Patrik Rorsman and team from @ocdem, @SahlgrenskaAcad and @OxfordBRC show the GLP-1 derivative GLP-1(9–36) to possess a direct inhibitory effect on glucagon secretion - an effect that was lost in alpha cells from human donors with #T2D link.springer.com/article/10…
5
1
13
1,271
Risk Factors for Young-Onset Dementia in the UK Biobank 15 risk factors identified, yep diabetes in there 😉 but a few interesting ones & considerations @kamleshkhunti @scelee1 @ketandhatariya @EASDelearning @AskDrShashank @GoggleDocs @GeriSoc jamanetwork.com/journals/jam…

Risk Factors for Young-Onset Dementia in the UK Biobank

This cohort study examines factors that are associated with the incidence of young-onset dementia among UK Biobank participants.

jamanetwork.com
1
16
1,149
This study on 13,461 real-world users of the MiniMed 780G system showed a high mean TITR (>48%). Consistent use of optimal settings improved mean TITR (>56%). @ADA_Pubs Read Here➡️doi.org/10.2337/dc23-1581
Graphical Abstract

ALT Graphical Abstract

6
1
23
2,672
We highlighted the association between low C-peptide levels and higher presence of low muscle mass and the cutoff value of C-peptide level at 1.15 ng/mL as a potential biomarker for low muscle mass. @ADA_Pubs Read Here➡️doi.org/10.2337/dc23-1168
Restricted cubic spline of the association between serum C-peptide levels and low muscle mass.

ALT Restricted cubic spline of the association between serum C-peptide levels and low muscle mass.

14
2
34
2,277
Thank you to all of #diabeteschat guest speakers of 2️⃣0️⃣2️⃣3️⃣. 4️⃣7️⃣ community chats & events 8️⃣6️⃣+ guest speakers You can listen back on our website: diabeteschat.net/guest-speak… Or watch on our YouTube channel: youtube.com/@diabeteschat?si…
3
12
4
38
3,773
Replying to @ShivaniM_KC
@ShivaniM_KC @ketandhatariya @professorcm @RozalinaMD @DavidKlonoff Data coming up for our document! @AmDiabetesAssn @EASDelearning @ABCDiab
Diabetes Care, an ADA research journal 🌟@DiabetesCareADA24 Dec 2023
A national cohort study presents data on patients with HHS and estimates an incidence rate of 16.5 and 3.9 per 10,000 person-years among persons with type 1 and 2 diabetes. @ADA_Pubs Read Here➡️doi.org/10.2337/dc23-0988
Graphical Abstract

ALT Graphical Abstract

3
6
1,567
EASDelearning retweeted
Neurodiab@Neurodiab_eu25 Dec 2023
Falls, postural instability, and vestibular dysfunction in people with T2D with and without diabetic polyneuropathy On Neurodiab website a signaling of articles on #diabeticneuropathy The 102nd NEUROdiab Publication News is by Shazli Azmi (neurodiab.eu/publication-new…)
7
14
838
EASDelearning retweeted
GoggleDocs
@GoggleDocs22 Dec 2023
Do GLP-1 receptor agonists improve cardiovascular outcomes in people with #type2diabetes & #NAFLD / #MASLD❓ 🔸Large 🇺🇸 cohort study 👉GLP1 vs SGLT2i - outcomes similar 👉GLP1 vs Metformin ⤵️💔, ⤵️⚡️🧠 & ⤵️☠️ 👉GLP vs other glucose-lowering ⤵️MACE, ⤵️💔, ⤵️⚡️🧠, ⤵️☠️ ⚠️observational - unresolved bias likely 🔗link.springer.com/article/10… @DrAKrishnanMD @kamleshkhunti @Dralbalawi1989 @drshafikuchay
3
60
78
4,650
A terrific scientific statement from the @American_Heart on the pathogenesis and current management of diabetic foot ulcers in cardiovascular patients. Via @CircAHA @PrashVas @AbdTahrani @EASDelearning @cristinatejerap ahajournals.org/doi/10.1161/…
6
17
1,568
EASDelearning retweeted
GoggleDocs
@GoggleDocs24 Dec 2023
❗️An early Christmas 🎄 present from us Goggledocs! A look back on GLP-1s from early clinical use to now and next❗️ ➡️ youtu.be/E2G1759GVkQ?si=jvhB… ⬅️ @drpatrickholmes @AmarPut @dr_amritlamba @kamleshkhunti @DLBHATTMD
2
12
24
2,456
Load more